Friday, April 3, 2026
30.4 C
Bengaluru

Entrepreneurial Mindset

MedicinMan September 2016

[wpfilebase tag=file id=82 tpl=download-button /]

Inside this Issue

1. Guest Editorial: In Pharma Sales, The Sky’s the Limit if You Have an ‘Entrepreneurial’ Mindset by Vivek Hattangadi
The biggest factor for success in the profession is ‘mindset’. Those with a ‘growth mindset’ see opportunities where others see only problems.

2. Rural Marketing: Challenges and Opportunities for Indian Pharma by Chandan Kumar
A very unique set of challenges but an ocean of untapped opportunity, make rural markets an exciting place for resourceful pharma marketers?

3. Book Review: The Three Box Solution by Vijay Govindarajan by Reviewed by K. Hariram
International strategy guru Vijay Govindarajan on how to effectively manage the present without losing sight of the future.

4. #Finding60InIndia: the Campaign to Raise Progeria Awareness in India by Preeti Mohile
How an integrated media campaign helped identify children living with Progeria in India – a disease that affects 1 in 20 million people.

5. Properties of a Highly Effective Leader: Learning from Pharmacology by Mrudul Kansara
What the properties of chemical substances can teach us about effective leadership.

Hot this week

Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales

Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...

Trump’s 100% Drug Tariffs Explained: The Surprising Opportunity for India

How the 2026 U.S. tariff action on branded drugs...

Can Eli Lilly Outrun the Same-Glutide Stampede with Tirzepatide and Orforglipron?

The "aspirinization" of obesity—moving from a niche, high-cost injectable...

IPM February 2026: Market Intelligence Report

Executive Summary The Indian Pharmaceutical Market (IPM) sustained its growth...

FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare

When drones first appeared on battlefields, military establishments reacted...

Topics

Hype and Happening: GLP-1 Growth Story – Follow the Patient, not the Primary Sales

Is Obesity (Drugs) Masking Underlying (Metabolic) Risk Factors in...

Can Eli Lilly Outrun the Same-Glutide Stampede with Tirzepatide and Orforglipron?

The "aspirinization" of obesity—moving from a niche, high-cost injectable...

IPM February 2026: Market Intelligence Report

Executive Summary The Indian Pharmaceutical Market (IPM) sustained its growth...

FieldForce Is Not Your Frontline Anymore. Meet the New Force in Healthcare

When drones first appeared on battlefields, military establishments reacted...

Razumab at 11: A Decade of Disruption, Safety Lessons, and the New Biosimilar Reality

Abstract When Intas Pharmaceuticals launched Razumab in June 2015 as...

Semaglutide: Just Another Off-Patent Generic? Or a Different Beast Entirely?

As over 50 generic versions of the blockbuster weight-loss...
spot_img

Related Articles

spot_imgspot_img